Preliminary (12 weeks) Results from trial of Denosumab for Acute Charcot Neuroarthropathy
UNSWorks (University of New South Wales, Sydney, Australia) · 06.08.2025
DOI: 10.26190/unsworks/31431 ↗Kurz gefasst
Fachartikel in der Zeitschrift UNSWorks (University of New South Wales, Sydney, Australia), erschienen am 06.08.2025. Verfasst von Namson S. Lau und 2 weiteren Autor:innen.
Abstract (Originalsprache)
BACKGROUND Clinical Features & Outcomes Charcot Neuroarthropathy (CN) can affect any joint, but in people with diabetes it mostly affects feet and ankles * Active CN typically presents as a warm, swollen & hot foot, often but not always following a precipitating injury * If unrecognised or under treated, progressive inflammation, swelling and foot deformity develops * CN is associated with increased rates of foot infection, osteomyelitis, lower limb amputation and CVD related death * Recruitment & data collection is continuing (target n = 36) * However as preliminary results are promising and as effect size larger than originally anticipated interim analysis at n = 15 completers * Above needed to inform placebo controlled randomised clinical trial, which is necessary to validate findings CONCLUSIONS * Charcot Neuroarthropathy (CN) is an uncommon but under recognised and potentially devastating form of diabetic foot disease (DFD) * Current treatments are both costly & complex while not addressing underlying disease processes * Research into CN is challenging but need is clear * The preliminary results from our trial of denosumab for active CN indicates a positive effect on CN disease activity * These promising results, if validated, could have a significant impact on the clinical outcomes and health care costs for a costly form of DFD The authors gratefully acknowledge project funding from Diabetes Australia
Schlagwörter
Zitieren
APA
Lau, N. S., Malone, M., & Dickson, H. G. (2025). Preliminary (12 weeks) Results from trial of Denosumab for Acute Charcot Neuroarthropathy. UNSWorks (University of New South Wales, Sydney, Australia). https://doi.org/10.26190/unsworks/31431
Vancouver
Lau NS, Malone M, Dickson HG. Preliminary (12 weeks) Results from trial of Denosumab for Acute Charcot Neuroarthropathy. UNSWorks (University of New South Wales, Sydney, Australia). 2025. doi:10.26190/unsworks/31431
BibTeX
@article{Lau2025,
author = {Lau, Namson S. and Malone, Matthew and Dickson, Hugh Grant},
title = {Preliminary (12 weeks) Results from trial of Denosumab for Acute Charcot Neuroarthropathy},
journal = {UNSWorks (University of New South Wales, Sydney, Australia)},
year = {2025},
doi = {10.26190/unsworks/31431}
}
EUVIMED